Zacks: Brokerages Expect Silicon Laboratories (NASDAQ:SLAB) Will Post Quarterly Sales of $206.61 Million

Analysts expect that Silicon Laboratories (NASDAQ:SLAB) will announce sales of $206.61 million for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Silicon Laboratories’ earnings, with estimates ranging from $205.00 million to $207.04 million. Silicon Laboratories posted sales of $217.11 million in the same quarter last year, which suggests a negative year-over-year growth rate of 4.8%. The company is scheduled to issue its next earnings results before the market opens on Wednesday, July 24th.

On average, analysts expect that Silicon Laboratories will report full-year sales of $843.37 million for the current fiscal year, with estimates ranging from $836.11 million to $846.70 million. For the next financial year, analysts forecast that the company will report sales of $929.95 million, with estimates ranging from $908.91 million to $950.00 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Silicon Laboratories.

Silicon Laboratories (NASDAQ:SLAB) last announced its earnings results on Wednesday, April 24th. The semiconductor company reported $0.59 EPS for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.12. Silicon Laboratories had a net margin of 7.35% and a return on equity of 10.74%. The firm had revenue of $188.11 million for the quarter, compared to analysts’ expectations of $188.02 million. During the same quarter in the previous year, the business posted $0.87 EPS. The company’s quarterly revenue was down 8.4% on a year-over-year basis.



A number of analysts have recently commented on the stock. BidaskClub upgraded shares of Zumiez from a “sell” rating to a “hold” rating in a report on Saturday, June 22nd. Zacks Investment Research upgraded shares of Twin Disc from a “strong sell” rating to a “hold” rating in a report on Saturday. ValuEngine upgraded shares of Alleghany from a “hold” rating to a “buy” rating in a report on Friday, April 19th. Wells Fargo & Co restated a “buy” rating on shares of Allergan in a report on Tuesday, June 25th. Finally, MKM Partners lifted their price target on Silicon Laboratories to $105.00 in a research report on Thursday, April 25th. Seven research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $105.70.

In other news, Director William G. Bock sold 1,000 shares of Silicon Laboratories stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $105.61, for a total value of $105,610.00. Following the completion of the transaction, the director now owns 39,791 shares of the company’s stock, valued at approximately $4,202,327.51. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Jack R. Lazar sold 750 shares of Silicon Laboratories stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $109.75, for a total value of $82,312.50. Following the completion of the transaction, the director now directly owns 14,391 shares of the company’s stock, valued at approximately $1,579,412.25. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,663 shares of company stock valued at $271,380. 2.10% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. NumerixS Investment Technologies Inc purchased a new position in Silicon Laboratories in the 4th quarter worth about $71,000. Quadrant Capital Group LLC raised its position in Silicon Laboratories by 866.0% in the 1st quarter. Quadrant Capital Group LLC now owns 995 shares of the semiconductor company’s stock worth $79,000 after buying an additional 892 shares during the last quarter. Advisor Group Inc. raised its position in Silicon Laboratories by 13.9% in the 4th quarter. Advisor Group Inc. now owns 1,345 shares of the semiconductor company’s stock worth $106,000 after buying an additional 164 shares during the last quarter. Stephens Inc. AR raised its position in Silicon Laboratories by 47.9% in the 4th quarter. Stephens Inc. AR now owns 2,015 shares of the semiconductor company’s stock worth $159,000 after buying an additional 653 shares during the last quarter. Finally, FNY Investment Advisers LLC purchased a new position in Silicon Laboratories in the 1st quarter worth about $161,000. 92.05% of the stock is owned by hedge funds and other institutional investors.

Shares of SLAB stock traded up $1.24 during mid-day trading on Friday, reaching $106.09. 219,402 shares of the company’s stock traded hands, compared to its average volume of 242,971. Silicon Laboratories has a 12 month low of $73.13 and a 12 month high of $110.43. The firm has a market cap of $4.54 billion, a P/E ratio of 37.09, a P/E/G ratio of 3.22 and a beta of 1.62. The company has a current ratio of 6.04, a quick ratio of 5.52 and a debt-to-equity ratio of 0.34. The firm’s 50-day simple moving average is $98.68.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, including 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, such as multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.

Recommended Story: Growth and Income Funds

Get a free copy of the Zacks research report on Silicon Laboratories (SLAB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.